| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |